Stay updated on iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 to v3.7.0. This indicates a backend update to the page without changes to the displayed study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:01:25.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor maintenance update to the study page with no evident changes to study content.
    Difference
    0.1%
    Check dated 2026-09-01T20:33:04.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, signaling a new build or update to the page content. This is a routine maintenance version change rather than a content change affecting study details.
    Difference
    0.1%
    Check dated 2026-08-11T18:30:06.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the page.
    Difference
    0.1%
    Check dated 2026-07-28T10:52:22.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.2 to v3.6.3, representing a small metadata update to the page. No content or functionality appears to be affected.
    Difference
    0.1%
    Check dated 2026-07-07T01:11:34.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2, representing a small build update to the page. No content changes to the study details are reflected.
    Difference
    0.1%
    Check dated 2026-06-29T19:01:47.000Z thumbnail image

Stay in the know with updates to iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.